ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,039Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 2035

$1.28M Total Retail Price of All Prescriptions

Rank: 22 out of 2035

376 Patients Receiving at Least One Drug in Part D
17%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

67% of this provider’s 376 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

66% of this provider’s 376 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 2,204 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 2,022 231 S3 1 2
OXYCODONE HCL 1,333 205 S2 2 62
CARISOPRODOL 618 40 R 3 57
LISINOPRIL 590 98 4 3
PROAIR HFA 482 56 5 31
OMEPRAZOLE 432 73 6 5
AMLODIPINE BESYLATE 321 65 7 6
SIMVASTATIN 313 45 8 1
FUROSEMIDE 279 32 9 7
RANITIDINE HCL 246 53 10 28
METHADONE HCL 242 19 S2 11 93
METFORMIN HCL 226 43 12 9
ZOLPIDEM TARTRATE 223 0 13 21
OPANA ER 221 28 S2 14 172
METOPROLOL TARTRATE 219 50 15 8
HYDROCHLOROTHIAZIDE 189 25 16 12
ADVAIR DISKUS 186 12 17 38
GABAPENTIN 176 19 18 14
NEXIUM 158 0 19 51
NAPROXEN 152 13 20 92
MORPHINE SULFATE ER 140 0 S2 21 86
LEVOTHYROXINE SODIUM 133 14 22 4
CYCLOBENZAPRINE HCL 127 0 R 23 64
CLONIDINE HCL 125 20 24 61
LIDODERM 124 35 25 72
OXYCONTIN 118 13 S2 26 152
VENTOLIN HFA 116 33 27 80
BACLOFEN 113 0 28 112
POTASSIUM CHLORIDE 108 21 29 18
SERTRALINE HCL 106 0 30 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 106 29 30 26
CYMBALTA 105 0 32 59
LOSARTAN POTASSIUM 100 22 33 15
QUETIAPINE FUMARATE 97 0 34 70
FLUTICASONE PROPIONATE 93 0 35 29
PREDNISONE 91 0 36 36
ATORVASTATIN CALCIUM 85 28 37 13
SPIRONOLACTONE 85 19 37 65
QVAR 85 0 37 234
SYMBICORT 81 0 40 107
TAMSULOSIN HCL 81 0 40 25
LEVETIRACETAM 81 0 40 87
PHENYTOIN SODIUM EXTENDED 79 0 43 132
TRAMADOL HCL 78 0 44 19
CARVEDILOL 77 35 45 22
ALLOPURINOL 76 22 46 34
TOPIRAMATE 75 0 47 184
MORPHINE SULFATE 72 0 S2 48 183
SPIRIVA 66 16 49 44
DIVALPROEX SODIUM 65 0 50 75
FLUCONAZOLE 64 0 51 198
TRIAMCINOLONE ACETONIDE 63 0 52 142
HYDRALAZINE HCL 60 0 53 45
ABILIFY 59 0 54 174
ATENOLOL 54 0 55 10
COLCRYS 53 27 56 186
IBUPROFEN 50 12 57 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 22, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.